SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today reported that it has received approval to Start Phase II Clinical Trial of ...

National Air and Space Museum research and curatorial associate director Jeremy Kinney provided introductory remarks before leading C-SPAN on a tour of the Smithsonian's facility in Washington, D.C.

Discover the new cryptos for big ROI in 2025, led by BullZilla’s high-growth presale and strong market momentum.

An RNA-based therapeutic approach led to transient activation of telomerase activity in a model of pulmonary fibrosis. A new report suggests that RNA-based human telomerase reverse transcriptase ...

The race to claim dominance among crypto presales in Q4 2025 is heating up, and two names are drawing particular attention: ...

Amazon has promised that PlayStation devices will go on sale as part of its Black Friday sale this year, but those deals are ...

It streamlines supply chains, connects producers with processors and global markets, and enhances product efficiency and profitability ...

Below is a deep dive into the five best crypto presales to buy today, and why LivLive is the one dominating whale interest ...

A scientist in Japan has developed a technique that uses brain scans and artificial intelligence to turn a person’s mental images into descriptive sentences.

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be ...

Revenue Increases 568% Year-over-Year and 78% Sequentially to $4.94 Million Q3 2025 Net Income Reaches $65.59 Million Driven by Ethereum Accumulation ETH Holdings Increased to 70,322, Valued at $291.5 ...

Angelie: Good morning. My name is Angelie, and I will be your conference operator today. At this time, I would like to ...